Epidemiology and treatment of post-stroke depression

Research output: Contribution to journalArticle

Abstract

Mood depression is a common and serious complication after stroke. According to epidemiological studies, nearly 30% of stroke patients develop depression, either in the early or in the late stages after stroke. Although depression may affect functional recovery and quality of life after stroke, such condition is often ignored. In fact, only a minority of patients is diagnosed and even fewer are treated in the common clinical practice. Moreover, the real benefits of antidepressant (AD) therapy in post-stroke depression have not been fully clarified. In fact, controlled studies on the effectiveness of ADs in post stroke depression (PSD) are relatively few. Today, data available suggest that ADs may be generally effective in improving mood, but guidelines for the optimal treatment and its length are still lacking.

Original languageEnglish
Pages (from-to)145-154
Number of pages10
JournalNeuropsychiatric Disease and Treatment
Volume4
Issue number1 A
Publication statusPublished - 2008

Keywords

  • Antidepressant
  • Depression
  • Stroke

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'Epidemiology and treatment of post-stroke depression'. Together they form a unique fingerprint.

  • Cite this